☰ Navigation Tabs
An scFv derived from ixekizumab External Resource: Annotation Chains Family Name Domain Identifier Architecture Possible Homology Homology Topology Family Provenance Source (Version) A Glyco_hydro_32N e6nouA1 A: alpha arrays X: Ten stranded beta/alpha barrel H: Ten stranded beta/alpha barrel T: Ten stranded beta/alpha barrel F: Glyco_hydro_32N ECOD (v295.2)
Chain Protein Name Description Organism Name Gene Allele Name(s) Domain Name(s) Receptor Type Receptor Description Provenance Source scFv ixekizumab SCFV-HEAVY-KAPPA Homo sapiens (human) IGHV1-69*01, IGHV1-69*11, IGHV1-69*12, IGHV1-69*13, IGHV1-69D*01, IGHV1-69*15, IGHJ4*01, IGHJ4*02, IGHJ4*03, IGKV2D-29*02, IGKJ2*02 V-DOMAIN VH, V-DOMAIN V-KAPPA IG SCFV-HEAVY-KAPPA IMGT (202644-0)
Chain Chain Class Chain Subclass Chain Type Antigen Name(s) Provenance Source Light Chain, Heavy Chain IGKV2, IGHV1 - - SAbDab (2026-11-13)
Chain Name Target Provenance Source Ixekizumab IL17A Therapeutic SAbDab (2026-11-13)